Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001787306-24-000153
Filing Date
2024-11-06
Accepted
2024-11-06 16:07:37
Documents
66
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q arqt-20240930.htm   iXBRL 10-Q 1142386
2 EX-31.1 exhibit311ceoq32024.htm EX-31.1 10832
3 EX-31.2 exhibit312cfoq32024.htm EX-31.2 10793
4 EX-32.1 exhibit321ceocfoq32024.htm EX-32.1 6990
  Complete submission text file 0001787306-24-000153.txt   6216323

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20240930.xsd EX-101.SCH 43934
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20240930_cal.xml EX-101.CAL 61852
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20240930_def.xml EX-101.DEF 205373
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20240930_lab.xml EX-101.LAB 611394
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20240930_pre.xml EX-101.PRE 419659
68 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20240930_htm.xml XML 764183
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

EIN.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39186 | Film No.: 241430939
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)